| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
|---|
|
Total Revenue
|
435,285,000
|
401,950,000
|
292,119,000
|
203,623,000
| | Cost of Revenue | 300,156,000 | 282,477,000 | 198,060,000 | 135,987,000 | | |
Gross Profit
|
135,130,000
|
119,473,000
|
94,058,000
|
67,637,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 373,817,000 | 351,910,000 | 256,343,000 | 179,353,000 | | | |
Operating Income or Loss
|
61,468,000
|
50,039,000
|
35,775,000
|
24,270,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 61,468,000 | 50,039,000 | 35,775,000 | 24,270,000 |
|
Interest Expense | (13,596,000) | (11,658,000) | (5,665,000) | (3,003,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 20,388,000 | 14,257,000 | 11,608,000 | 7,438,000 |
|
Minority Interest | (975,000) | 314,000 | (683,000) | (1,162,000) |
|
|
|
Net Income From Continuing Ops | 53,150,000 | 30,170,000 | 23,254,000 | 22,401,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
54,507,000
|
37,895,000
|
23,254,000
|
22,401,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.54%